Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)
LV Prasad Eye Institute founder recognized for his pioneering contribution to affordable and accessible eye care; award celebrates two decades of honoring transformative humanitarian leadership.
Marketing leader behind growth of brands such as Cipladine, Maxirich, and Soak Shield takes on expanded responsibilities to drive portfolio growth and consumer engagement.
.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
CEO Stéphane Bancel framed the changes as essential to scaling the business
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
